Ambulatory seizure detection

Adriano Bernini,Jonathan Dan,Philippe Ryvlin
DOI: https://doi.org/10.1097/wco.0000000000001248
2024-03-08
Current Opinion in Neurology
Abstract:Reliable ambulatory seizure detection systems have become a major expectation for persons with epilepsy, their families and their physicians, with the double aim of triggering timely alarms to mitigate the potential harmful consequences of seizures and providing more precise information on seizure frequency to better guide therapy [1] . Indeed, this essential information currently relies on reports from patients or their caregivers, which often prove inaccurate or misleading [2–5] . Accordingly, surveys indicate that over 75% of individuals with epilepsy consider real-time seizure detection as highly important [6] . Yet, recent guidelines from the international league against epilepsy and world federation of clinical neurophysiology have concluded that current wearable devices can only reliably detect generalized tonic-clonic seizures (GTCS) and focal to bilateral tonic-clonic seizures, all of which will be referred as GTCS herein [7▪▪,8▪▪] . Furthermore, there is currently no evidence that using such device decreases the risk of sudden unexpected death in epilepsy (SUDEP) [7▪▪,8▪▪] .
neurosciences,clinical neurology
What problem does this paper attempt to address?